UCLA Health
At UCLA Health, we provide the best health care, using the latest medical technology — healing humankind one patient at a time.
- 2024 Heart Failure Symposium
- 17th Annual UCLA Liver Diseases Symposium
- 12th Annual UCLA-Mellinkoff GI and Hepatology Symposium
- Personalized Nutrition in Primary Care 2024
- 2023 Heart Failure Symposium
- 2023 UCLA ECMO and Life Support Symposium
- 11th Annual UCLA-Mellinkoff GI and Hepatology Symposium
- 15th Annual UCLA Liver Diseases Symposium
- Neurosurgery
- Nephrology
- Cardiovascular
- Oncology
- Liver Grand Rounds
- Liver Hour
- Gastroenterology
- Advanced Lung Disease and Lung Transplantation Symposium 2023
- 16th Annual UCLA Liver Diseases Symposium
- Personalized Nutrition 2022
- 2024 Advanced Lung Disease and Lung Transplantation Symposium
- Events
Playback speed
10 seconds
Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Metastatic Pancreatic Cancer
By
UCLA Health
FEATURING
Zev A. Wainberg
By
UCLA Health
FEATURING
Zev A. Wainberg
286 views
March 8, 2024
Comments 0
Login to view comments.
Click here to Login